- Featured Product
- KD/KO Validated
SGLT2 Polyklonaler Antikörper
SGLT2 Polyklonal Antikörper für WB, IHC, IF-P, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF-P, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 24654-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
24654-1-PBS bindet in WB, IHC, IF-P, ELISA SGLT2 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | SGLT2 fusion protein Ag19163 |
| Vollständiger Name | solute carrier family 5 (sodium/glucose cotransporter), member 2 |
| Berechnetes Molekulargewicht | 672 aa, 73 kDa |
| Beobachtetes Molekulargewicht | 69-70 kDa |
| GenBank-Zugangsnummer | BC131542 |
| Gene symbol | SGLT2 |
| Gene ID (NCBI) | 6524 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Sodium-glucose cotransporter 2 (SGLT2), encoded by SLC5A2, utilizes the electrochemical sodium gradient to transport glucose against the cell's internal concentration gradient. Mainly expressed on brush border membrane (BBM) of epithelial cells in the early segment of the proximal tubule, SGLT2 mediates most of the glucose reabsorption by the kidney overall. Inhibition of SGLT2 could improve glucose homeostasis of diabetic patients, which has been considered as a novel strategy for diabetes treatment.





















